BACE1, the Alzheimer's beta-secretase enzyme, in health and disease

  • Vassar R
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Interestingly, impaired glucose metabolism occurs early in AD, and our work has demonstrated that glucose deprivation increases BACE1 levels and Abeta production in the brains of an APP transgenic model of AD, the Tg2576 mouse. Genetic and pharmacological manipulation of eIF2alpha phosphorylation was performed in vitro experiments. eIF2alpha S51A knock-in mice and GADD34-AAV injection into mouse brain was used for manipulation of eIF2alpha phosphorylation in vivo.

Cite

CITATION STYLE

APA

Vassar, R. (2012). BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease. Molecular Neurodegeneration, 7(Suppl 1), L3. https://doi.org/10.1186/1750-1326-7-s1-l3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free